Search the Newsreel

SCYNEXIS Swings To Q2 Profit; Expects Phase 1 Topline Data For SCY-770 In Q3 2026;Stock Up

(RTTNews) - SCYNEXIS, Inc. (SCYX), a clinical-stage biotechnology company, reported financial results for the second quarter ended June 30, 2026, swinging to a net profit compared to a loss last year. In addition, the company provided an update on its investigational pipeline. Company Profile …

Scynexis Inc earnings beat by $1.14, revenue topped estimates

Scynexis Inc (NASDAQ: SCYX) reported strong second-quarter results, beating analyst EPS estimates by $1.14 with an EPS of $0.630. The company also exceeded revenue expectations, bringing in $240K against a consensus estimate of $80.33K. Despite the positive earnings, Scynexis Inc's stock has seen a …

NexMetals Mining (NASDAQ:NEXM) Shares Down 0.9% - What's Next?

NexMetals Mining (NASDAQ:NEXM) shares dropped 0.9% to $2.32 on Monday, with trading volume significantly lower than average. The stock remains below its 200-day moving average, and analyst sentiment is mixed, with a consensus "Hold" rating. Institutional investors have shown increased interest, despite analysts forecasting …

Dynex Capital, Inc. Declares Common Stock Dividend for the Month of August 2026, Payable on September 1, 2026

Dynex Capital, Inc. announced a cash dividend of $0.17 per share on its Common Stock for August 2026. The dividend is scheduled to be paid on September 1, 2026, to shareholders of record as of August 21, 2026. This announcement indicates the company's consistent …

Diginex Ltd (DGNX) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Diginex Ltd (DGNX), including future EPS and revenue growth estimates. It highlights the company's current stock performance, market capitalization, and various financial metrics such as P/E TTM. The report also lists peer comparisons with other technology companies …

Nexxen to Stream Three Executive Fireside Chats Online

Nexxen International Ltd. announced that its executive management and investor relations teams will participate in three upcoming financial conferences: the Canaccord Genuity Annual Growth Conference on August 12, the Rosenblatt Annual Technology Summit on August 18, and the Citi Global TMT Conference on September …

Quanex, Titan International, ESCO, Boise Cascade, and ChargePoint Stocks Trade Up and Down, What You Need To Know

Quanex, Titan International, ESCO, Boise Cascade, and ChargePoint Stocks Trade Up and Down, What You Need To Know What Happened? A number of stocks traded in opposite directions in the afternoon session after the July jobs report showed an unexpected loss of 23,000 jobs, …

NextVision Stabilized Systems (TASE:NXSN) Stock Can Profit Growth Justify The Pullback

Cognex Corp (CGNX) Shares Fall 3.8% -- What GF Score of 72 Tells Investors

Cognex Corp (CGNX) shares dropped 3.8%, making its current price of $64.36 23.7% above its GF Value of $52.05, suggesting the stock is "Modestly Overvalued." The company has a GF Score of 72/100, indicating an "Above Average" quality, primarily due to strong profitability and …

Form 8K Annexon Inc For: 10 August By Investing.com

This article announces that Annexon Inc. filed a Form 8K on August 10th. The filing is brief and does not contain additional details beyond the date of the filing and the company involved.

Nexus Industrial REIT Lifts Occupancy, Boosts NOI Amid Bond-Funded Expansion

Onex Partners and Co-Investors Complete Acquisition of AirSprint

ONEX Corporation All amounts in U.S. dollars unless otherwise stated TORONTO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Onex Partners today announced that the Onex Partners Opportunities Fund and certain other co-investors have completed their acquisition of AirSprint Inc. ("AirSprint"), the largest fractional jet operator …

Scynexis Q2 adjusted EPS misses estimate as sales decline 82.77%

SCYNEXIS Reports Second Quarter 2026 Financial Results and Provides Corporate Update

SCYNEXIS, Inc. (NASDAQ: SCYX) announced its second quarter 2026 financial results, highlighting a strong cash position of $71.1 million, which is expected to fund operations into 2029. The company provided updates

SCYNEXIS (NASDAQ:SCYX) Announces Quarterly Earnings Results, Beats Expectations By $1.14 EPS

SCYNEXIS GAAP EPS of $0.63 beats by $1.14, revenue of $0.24M beats by $0.16M

* SCYNEXIS press release [https://seekingalpha.com/pr/20613730-scynexis-reports-second-quarter-2026-financial-results-and-provides-corporate-update] (SCYX [https://seekingalpha.com/symbol/SCYX]): Q2 GAAP EPS of $0.63 beats by $1.14. * Revenue of $0.24M (-82.4% Y/Y) beats by $0.16M. * Cash, cash equivalents and investments totaled $71.1 million on June 30, 2026, compared to $56.3 million on December 31, …

Is Nexstar Media Group (NXST) Undervalued On Strong Q2 2026 Earnings?

Annexon appoints retinal surgeon Blumenkranz to board By Investing.com

Annexon, Inc. (NASDAQ:ANNX) has appointed retinal surgeon Mark S. Blumenkranz, M.D., M.M.S., to its board of directors. Concurrently, Muneer Satter will step down from the board after more than 11 years of service. Blumenkranz brings extensive experience from Stanford University and has co-founded several …

Annexon names Mark Blumenkranz to board as Muneer Satter steps down

Annexon has appointed retinal surgeon and biotech entrepreneur Mark S. Blumenkranz to its board of directors. Blumenkranz, a Stanford ophthalmology professor emeritus and co-director of its Ophthalmic Innovation Program, has a strong background in founding and leading ophthalmic companies. This appointment follows the stepping …

NextEra Energy Is Quietly Compounding. Does the 14% Pullback Make It a Buy?

NextEra Energy (NEE), the world's largest wind and solar energy producer, has consistently grown earnings and recently saw a 14% stock pullback. Despite interest rate sensitivities, its underlying business remains strong, with predictable earnings from Florida Power and Light and a growing backlog in …

Scynexis (NASDAQ: SCYX) lifts cash and pipeline with Q2 2026 moves

NextCure (NXTC) plans reverse merger with Avere and $820M financings

NextCure, Inc. (NXTC) and Avere Therapeutics are planning an all-stock reverse merger, with the combined entity to operate as Avere Therapeutics, Inc. and trade on Nasdaq under "AVRX." Avere announced a new $500 million private placement, in addition to a previously disclosed $320 million …

Virginia Governor Will Intervene in NextEra-Dominion Case

Virginia Governor Abigail Spanberger will formally intervene in NextEra Energy Inc.'s acquisition of Dominion Energy Inc., citing skepticism about the deal's benefits for Virginia. Her intervention aims to prioritize energy cost reduction, job protection, and clean-energy investments. Spanberger's concerns align with her focus on …

NextEra Energy (NEE) boosts profit and cash flow on strong Q2 2026 results

Cognex Sees Record Revenue, Margin Gains as AI Powers Machine-Vision Growth

Cognex (NASDAQ:CGNX) is experiencing record revenue and margin expansion, driven by strong demand in machine vision and the integration of AI. The company reported record second-quarter revenue of $290 million, with third-quarter guidance projecting another record at $310 million, and has significantly improved its …

Is StoneX Group (SNEX) a Solid Growth Stock? 3 Reasons to Think "Yes"

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock. By their very nature, these stocks carry above-average risk and volatility. …

Annexon Appoints Renowned Retinal Surgeon and Biotechnology Entrepreneur Mark S. Blumenkranz, M.D., M.M.S. to its Board of Directors

Annexon, Inc. (Nasdaq: ANNX) has appointed Dr. Mark S. Blumenkranz, a distinguished retinal surgeon and biotechnology entrepreneur, to its board of directors. Dr. Blumenkranz brings over four decades of experience in retinal disease innovation, which will be crucial as Annexon advances its late-stage clinical …

Cocoa Storm Gathers as Two Crops and El Nino Line Up Against Supply

The cocoa market is facing a potential supply crisis despite a currently well-supplied harvest. Prices are rising due to concerns over the 2026/27 and 2027/28 cocoa crops, which are threatened by poor West African weather and persistent El Nino conditions. StoneX has significantly cut …

NextNav (NN) Is Up 23.2% After Safran 5G PNT Deal News Is The Bull Case Changing?

NextNav (NN) saw its stock rise by 23.2% following news of a deal with Safran Electronics & Defense to integrate and test interoperability of NextNav's terrestrial 5G PNT network. This collaboration supports NextNav's core thesis of becoming an essential complement to GPS for critical …

Is StoneX Group (SNEX) Quietly Rewriting Its Core Strategy Through R.J. O’Brien Integration Progress?

StoneX Group recently reported strong Q3 2026 results with significant revenue and net income growth, alongside doubled EPS. The company is advancing its strategic initiatives by expanding its payments reach through a partnership with Shinhan Bank and integrating the R.J. O’Brien acquisition. These efforts …

NXSN: H1 2026 revenue surged 112% year-over-year, with a raised 2026 target of $355 million

SNEX Q2 Deep Dive: Revenue Growth Amid Margin Pressures and Integration Efforts

SNEX Q2 Deep Dive: Revenue Growth Amid Margin Pressures and Integration Efforts Financial services network StoneX Group (NASDAQ:SNEX) posted $39.68 billion of revenue in Q2 CY2026, up 15.2% year on year. Its GAAP profit of $1 per share was 8.7% below analysts' consensus estimates. …

Quanex Building Products Corpor (NX) Stock Forecasts

Argus has raised its target price for Quanex Building Products Corp (NX) to $20.00, while the current stock price is $21.06. Quanex is a manufacturer of components for original equipment manufacturers in the building products industry. The article also lists other related reports with …

CGNX Q2 Deep Dive: AI-Driven Growth and Product Diversification Shape Outlook

CGNX Q2 Deep Dive: AI-Driven Growth and Product Diversification Shape Outlook Machine vision technology company Cognex (NASDAQ:CGNX) fell short of the market's revenue expectations in Q2 CY2026, but sales rose 16.9% year on year to $291.3 million. On the other hand, next quarter's outlook …

How Much Upside is Left in Spartacus Acquisition (NN)? Wall Street Analysts Think 106.44%

Shares of NextNav Inc. (NN) have gained 1.9% over the past four weeks to close the last trading session at $16.31, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. …

Xcellon Biologics Acquires GMP Manufacturing Facility from NextCure, Becoming an End-to-End CRDMO for Next-Generation Bioconjugates and Complex Biologics

Xcellon Biologics has acquired a GMP biologics manufacturing facility from NextCure, Inc., transforming it into an end-to-end Contract Research, Development and Manufacturing Organization (CRDMO) specializing in bioconjugates and complex biologics. This acquisition integrates capabilities from discovery through clinical supply and strengthens U.S. biomanufacturing. Abhishake …